Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Fonseca

Showing results (11-20 of 1,163) with videos related to

Pageof 117
Sort By:
The American Journal of Medicine|January 4, 2011
Exploring the spectrum of incretin therapies: the potential for optimizing patient outcomes. IntroductionVivian A Fonseca
The American Journal of Medicine|January 4, 2011
Incretin-based therapies in complex patients: practical implications and opportunities for maximizing clinical outcomes: a discussion with Dr. Vivian A. FonsecaVivian A Fonseca
Clinical Cornerstone|February 14, 2006
The metabolic syndrome, hyperlipidemia, and insulin resistanceVivian A Fonseca
Clinical Cornerstone|December 27, 2007
Early identification and treatment of insulin resistance: impact on subsequent prediabetes and type 2 diabetesVivian A Fonseca
Journal of Clinical Hypertension (Greenwich, Conn.)|October 10, 2006
Insulin resistance, diabetes, hypertension, and renin-angiotensin system inhibition: reducing risk for cardiovascular diseaseVivian A Fonseca
Journal of Diabetes and Its Complications|October 15, 2013
How to get your paper published paper: an editor's perspectiveVivian A Fonseca
Anais Paulistas De Medicina E Cirurgia|October 29, 2010
Some interesting cases of postpartum hemorrhageG A FONSECA
European Journal of Internal Medicine|July 8, 2009
Demystifying incretin therapy for type 2 diabetes. IntroductionVivian A Fonseca
The American Journal of Medicine|September 14, 2007
Rationale for the use of insulin sensitizers to prevent cardiovascular events in type 2 diabetes mellitusVivian A Fonseca
Clinical Cornerstone|March 25, 2008
Insulin therapy in type 2 diabetes. IntroductionVivian A Fonseca
Pageof 117

Showing results (11-20 of 1,163) with videos related to

Sort By:
Pageof 117
The American Journal of Medicine|January 4, 2011
Exploring the spectrum of incretin therapies: the potential for optimizing patient outcomes. IntroductionVivian A Fonseca
The American Journal of Medicine|January 4, 2011
Incretin-based therapies in complex patients: practical implications and opportunities for maximizing clinical outcomes: a discussion with Dr. Vivian A. FonsecaVivian A Fonseca
Clinical Cornerstone|February 14, 2006
The metabolic syndrome, hyperlipidemia, and insulin resistanceVivian A Fonseca
Clinical Cornerstone|December 27, 2007
Early identification and treatment of insulin resistance: impact on subsequent prediabetes and type 2 diabetesVivian A Fonseca
Journal of Clinical Hypertension (Greenwich, Conn.)|October 10, 2006
Insulin resistance, diabetes, hypertension, and renin-angiotensin system inhibition: reducing risk for cardiovascular diseaseVivian A Fonseca
Journal of Diabetes and Its Complications|October 15, 2013
How to get your paper published paper: an editor's perspectiveVivian A Fonseca
Anais Paulistas De Medicina E Cirurgia|October 29, 2010
Some interesting cases of postpartum hemorrhageG A FONSECA
European Journal of Internal Medicine|July 8, 2009
Demystifying incretin therapy for type 2 diabetes. IntroductionVivian A Fonseca
The American Journal of Medicine|September 14, 2007
Rationale for the use of insulin sensitizers to prevent cardiovascular events in type 2 diabetes mellitusVivian A Fonseca
Clinical Cornerstone|March 25, 2008
Insulin therapy in type 2 diabetes. IntroductionVivian A Fonseca
Pageof 117